Bexley Dermatology Research

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Alopecia areata5 trials
• Atopic dermatitis (eczema)5 trials
• Psoriasis2 trials
• Vitiligo1 trial

Phase

• Phase 312 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed7 trials
• Active, not recruiting4 trials
• Recruiting3 trials

Lead sponsor

• Pfizer4 trials
• Amgen2 trials
• Eli Lilly and Company2 trials
• Janssen Research & Development, LLC2 trials
• Acrotech Biopharma Inc.1 trial
• and 3 more

Running trials

• Recruiting

  A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

  NCT07733765· Phase 3· Pfizer· Source

• Active, not recruiting

  Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)

  NCT07246590· Phase 3· Verrica Pharmaceuticals Inc.· Source

• Recruiting

  A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

  NCT06873945· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

  NCT06220604· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

  NCT06072183· Phase 3· Pfizer· Source

• Recruiting

  A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

  NCT05723198· Phase 3· Eli Lilly and Company· Source

  Contact: Matthew Zirwas (principal investigator)

• Active, not recruiting

  Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

  NCT03898479· Phase 2/3· Sun Pharmaceutical Industries, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alopecia areata3 recruiting

Closed trials

• Completed

  A Study With Self-administered Rocatinlimab in Adolescent and Adult Participants With Moderate-to-severe Atopic Dermatitis

  NCT06224192· Phase 3· Amgen· Source

• Completed

  Study of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area Moderate Plaque Psoriasis

  NCT06039189· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05724199· Phase 3· Amgen· Source

• Completed

  A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)

  NCT05717920· Phase 2· Aldeyra Therapeutics, Inc.· Source

• Completed

  A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

  NCT05571943· Phase 3· Acrotech Biopharma Inc.· Source

• Completed

  A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

  NCT03899259· Phase 3· Eli Lilly and Company· Source

• Completed

  Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

  NCT03422822· Phase 3· Pfizer· Source